MDMA: RESEARCH AREAS NEEDING MORE EMPHASIS

Document Type:	Grants Notice
Funding Opportunity Number:	PA-04-152
Posted Date:	Sep 08, 2004
Original Due Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
Current Due Date for Applications:	Multiple Receipt Dates - See Link to Full Announcement for details.
Archive Date:	Feb 01, 2008
Funding Instrument Type:	Grant
Category of Funding Activity:	Education Health
Expected Number of Awards:	Not Available.
Estimated Total Program Funding:	Not Available.
Award Ceiling:	none
Award Floor:	none
CFDA Number:	93.279 -- Drug Abuse Research Programs
Cost Sharing or Matching Requirement:	No

Eligible Applicants

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

For profit organizations other than small businesses

Small businesses

Public and State controlled institutions of higher education

Private institutions of higher education

State governments

County governments

City or township governments

Special district governments

Independent school districts

Native American tribal governments (Federally recognized)

Public housing authorities/Indian housing authorities

Native American tribal organizations (other than Federally recognized tribal governments)

Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Information on Eligibility:

Eligible agencies of the Federal Government are eligible to apply.
Foreign institutions are eligible to apply.

Agency Name

Description

The purpose of this PA is to provide an optimally comprehensive, strategic,
and balanced MDMA (3,4-methylenedioxymethamphetamine) research program, given
the upsurge in MDMA abuse worldwide, including its abuse outside the rave
scene.  Although researchers have made great strides in characterizing MDMAs
neural mechanisms and neurotoxicity, it is necessary now to focus on specific
areas of MDMA research, across all research disciplines, urgently needing our
attention.  

For the purpose of this PA, the term MDMA is defined as 3,4-
methylenedioxymethamphetamine and its very close structural analogues, such
as p-methoxyamphetamine (PMA), p-methoxymethamphetamine (PMMA), and 3,4-
methylenedioxy-N-ethyl-amphetamine (MDEA), insofar as they share specific
subjective, discriminative stimulus, or toxicological properties with 3,4-
methylenedioxymethamphetamine; however, methamphetamine and other
amphetamines that are characterized by neurotoxic effects on central
dopaminergic systems in experimental animals are not included in this
definition.  Ecstasy is defined as a preparation (usually a tablet)
supposed by its users to contain MDMA.

Link to Full Announcement

http://grants.nih.gov/grants/guide/pa-files/PA-04-152.html

If you have difficulty accessing the full announcement electronically, please contact:

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster NIH OER Webmaster

• HHS NIH listed by [Posted Date]
• HHS Agencywide listed by [Posted Date]